Start Madrid - Ciocc

Madrid 28050

2 studies enrolling now · 11 studies all time

What they study most

ALK-Positive Large B-Cell Lymphoma, Advanced Hematologic Tumors, Advanced Nonhaematologic Malignancies, Advanced Solid Tumor, Advanced Solid Tumors, Breast Cancer, Breast Carcinoma, Breast Diseases, Breast Neoplasms, Burkitt Lymphoma, Cervical Cancers, Cervical Carcinoma

Studies at this site

• A First-in-Human (FIH) Study to Evaluate the Safety and Tolerability of VVD-130037 in Participants With Advanced Solid Tumors — Recruiting now
• Study of SGR-1505 in Mature B-Cell Neoplasms — Recruiting now
• A Phase 1 Study of ATV-1601 in Patients With Advanced Cancer That Have AKT1 E17K Mutations — Running, not enrolling
• GEN1046 Safety Trial in Patients With Malignant Solid Tumors — Running, not enrolling
• A Study Evaluating ANV600 Single Agent or in Combination With Pembrolizumab in Participants With Advanced Solid Tumors (EXPAND-1) — Completed
• A First-in-Human (FIH) Study to Evaluate the Safety and Tolerability of VVD-130850 in Participants With Advanced Solid and Hematologic Tumors — Stopped early
• A Study of TAS-120 in Patients With Metastatic Breast Cancer — Stopped early
• Trastuzumab Deruxtecan With Nivolumab in Advanced Breast and Urothelial Cancer — Completed
• Safety, Efficacy, and Tolerability of BOS172738 in Patients With Advanced Rearranged During Transfection (RET) Gene-Altered Tumors — Completed
• GEN1029 (HexaBody®-DR5/DR5) Safety Trial in Patients With Malignant Solid Tumors — Stopped early
• Safety, Pharmacokinetic and Preliminary Efficacy Study of AC0010MA in Advanced Non Small Cell Lung Cancer — Stopped early